Biotech Values

[DewDiligence]

ISO IPOs 9.58M* shares @$15.00:

https://finance.yahoo.com/news/isoplexis-announces-pricing-initial-public-221200061.html

IsoPlexis is a life science technology company building solutions to accelerate the development of curative medicines and personalized therapeutics. Our award-winning single-cell proteomics systems reveal unique biological activity in small subsets of cells, allowing researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. Our integrated systems, named top innovation or design by the Scientist Magazine, Fierce, BIG Innovation, Red Dot & multiple others, are used globally to advance the field of single-cell biology into new 'omic possibilities, as our customers generate solutions to overcome the challenges of complex diseases and therapeutics. Our products have been adopted by researchers around the world, including the top 15 global pharmaceutical companies by revenue and by nearly half of comprehensive cancer centers in the U.S.

After reading the above, I can’t tell what this company does. Caveat emptor.

*Assuming exercise of underwriter’s option.